(IN BRIEF) Almirall is reinforcing its commitment to innovation in medical dermatology, with a focus on science, collaboration and patient needs. The company’s teams work to improve understanding of skin diseases and address complex dermatological challenges through research and multidisciplinary … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Spain, Technology
Tagged Almirall, Almirall Combines Science and Patient Insight to Advance Medical Dermatology, Almirall Highlights Purpose-Led Innovation in Dermatology, Almirall Strengthens Scientific Focus on Skin Disease Research, better care, Dermatology, dermatology innovation, dermatology pipeline, disease understanding, Healthcare Innovation, healthier future, innovation through science, long-term ambition, medical dermatology, multidisciplinary teams, patient needs, patient outcomes, patient wellbeing, patient-centred innovation, patients’ lives, purpose-led science, quality of life, research collaboration, researchers, scientific excellence, scientific expertise, scientific research, scientists, skin conditions, skin disease research, skin diseases, skin science, treatment innovation, unmet medical needs
(IN BRIEF) Accenture has agreed to acquire Alfahealth, a subsidiary of Engineering Group, to strengthen its digital health capabilities and healthcare transformation services in Italy. Alfahealth brings more than two decades of experience in developing and operating healthcare technology through … Read the full press release
Posted in Artificial Intelligence (AI), Business, European Union, Healthcare, Internet & Online, Investment, Ireland, Italy, Management, Security & Safety, Technology
Tagged 1, 200 Digital Health Professionals into Accenture Italy’s Health Practice, 200 professionals, Accenture, Accenture Italy, Accenture Strengthens Italian Healthcare Practice with Planned Acquisition of Alfahealth from Engineering Group, acquisition, administrative processes, AI-powered platforms, Alfahealth, Alfahealth Acquisition to Bring 1, artificial intelligence, clinical workflows, Cloud, connected care, Cybersecurity, data, data interoperability, diagnostics, digital health, engineering group, healthcare institutions, healthcare providers, healthcare technology, healthcare transformation, integrated care, Italian healthcare market, Italy, Milan, national healthcare programmes, operational processes, patient access, patient experience, patient journeys, patient outcomes, regulated healthcare environment, services-plus-product model, Teodoro Lio
(IN BRIEF) A University of Liverpool-led research team has received more than £475,000 from Blood Cancer UK to continue and expand UNCOVER, one of the largest blood cancer data research programmes globally. Sponsored by The Clatterbridge Cancer Centre, the programme … Read the full press release
Posted in Education, Government, Healthcare, Non Profit, Science, United Kingdom
Tagged blood cancer patients, blood cancer research, Blood Cancer UK, Blood Cancer UK Backs Three-Year Expansion of National UNCOVER Research Programme on Blood Cancer Diagnosis and Care, cancer care pathways, cancer diagnosis, cancer treatment, clinical research, Consultant Haemato-Oncologist, data research programme, early-career researchers, England, health data science, health inequalities, Institute of Population Health, international scientific conferences, national advisory group, New Funding Supports UNCOVER’s Use of NHS Data to Improve Blood Cancer Care and Outcomes, NHS data, NHS decision-making, patient involvement, patient outcomes, peer-reviewed manuscripts, Professor Andrew Pettitt, Professor Catrin Tudur Smith, real-world care, Ronald Finn Professor of Experimental Medicine, routinely collected NHS data, The Clatterbridge Cancer Centre, UNCOVER, UNCOVER Blood Cancer Data Programme Secures New Funding to Strengthen Real-World Research Across England, University of Liverpool, University of Liverpool Team to Expand One of the World’s Largest Blood Cancer Data Research Programmes
(IN BRIEF) Bayer has highlighted an important development in cardiovascular health assessment following the Saudi Heart Association’s recent publication recommending greater focus on the early detection of subclinical atherosclerosis in clinical practice. The research supports a more personalized approach to … Read the full press release
Posted in Business, Government, Healthcare, Pharma & Biotech, Science, Society, Switzerland, Technology
Tagged ABI, ankle-brachial index, Atherosclerosis, Bayer, Bayer Advances Cardiovascular Health Assessment Through Focus on Subclinical Atherosclerosis Screening, Bayer and Saudi Heart Association Collaboration Strengthens Focus on Preventive Cardiovascular Care, Bayer Consumer Health, Bayer Supports Early Cardiovascular Risk Detection Following New Saudi Heart Association Recommendations, CAC scoring, cardiac care, cardiovascular disease, cardiovascular health, cardiovascular risk assessment, carotid ultrasound, CCTA, Clinical Practice, Consumer Health division, coronary artery calcium scoring, coronary computed tomography angiography, CVD, Dr. Ricardo Salazar, Early Detection, family history, Gasser Yousry, genetic predisposition, healthcare professionals, heart attack, high cholesterol, hypertension, modifiable risk factors, Non-invasive Imaging, non-modifiable risk factors, patient outcomes, personalized cardiovascular care, physical inactivity, policymakers, poor diet, Prevention Strategies, primary prevention, Prof. Dr. Waleed Al Habeeb, researchers, risk re-stratification, risk stratification, Saudi Arabia, Saudi Heart Association, Saudi Heart Association Research Aligns with Bayer’s Personalized Approach to Cardiovascular Risk Prevention, secondary prevention, SHA, smoking, stroke, subclinical atherosclerosis, Vision 2030
(IN BRIEF) The University of Warwick-coordinated OPTIMA trial, sponsored by University College London, has found that the Prosigna genomic test could help many patients with early-stage hormone-sensitive breast cancer avoid unnecessary chemotherapy without compromising outcomes. The trial followed more than … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged Adrienne Morgan, American Society of Clinical Oncology, ASCO Annual Meeting, breast cancer, breast oncology, cancer recurrence, cancer research, Cardiff, chemotherapy, clinical trial, early stage breast cancer, gene test, genomic test, hormone therapy, hormone-sensitive breast cancer, Independent Cancer Patients’ Voice, Karen Bonham, lymph nodes, Major OPTIMA Trial Results Could Support Wider NHS Use of Genomic Testing to Reduce Chemotherapy Overtreatment, National Institute for Health and Care Research, NHS, NHS laboratories, Nice, NIHR, OPTIMA trial, Patient and Public Involvement, patient outcomes, personalised treatment, Professor Janet Dunn, Professor Rob Stein, Prosigna, radiotherapy, treatment decision-making, tumour biology, UCL, UCL Cancer Institute, University College London, University of Warwick, University of Warwick and UCL-Led Breast Cancer Trial Highlights Potential to Spare Thousands from Chemotherapy, University of Warwick-Coordinated OPTIMA Trial Shows Genomic Test Could Help Breast Cancer Patients Avoid Unnecessary Chemotherapy, unnecessary chemotherapy, Veracyte Inc, Warwick Clinical Trials Unit
(IN BRIEF) Researchers from the University of Twente, ZGT, and MST are developing the Twente foot model, a predictive 3D tool designed to improve surgical outcomes for patients with severe diabetic foot deformities. By combining imaging data and pressure measurements, … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Netherlands, Science, Technology
Tagged 3D medical imaging, Biomechanics, Charcot foot, diabetic foot, digital health, foot surgery, Healthcare Innovation, Innovative Twente Foot Model Brings Precision and Predictive Planning to Complex Diabetic Foot Surgeries, Kilian Kappert, medical technology, MST, patient outcomes, PIHC Innovation fund, predictive modeling, reconstructive surgery, Reggeborgh fellowship, Sam Kroezen, Twente foot model, University of Twente, Wouter ten Cate, ZGT
(IN BRIEF) New data presented at EHRA 2026 show that individuals with atrial fibrillation detected through screening face a threefold higher risk of developing heart failure compared with those without AF, with a risk level similar to patients with known … Read the full press release
Posted in Business, Education, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Society, Technology
Tagged AF screening, asymptomatic AF, atrial fibrillation, cardiology, cardiovascular disease, clinical research, ECG screening, EHRA 2026, EHRA 2026 Study Shows Screening Identified AF Carries Similar Heart Failure Risk as Diagnosed Cases, European Heart Rhythm Association, European Society of Cardiology, Gina Sado, heart failure, patient outcomes, STROKESTOP, STROKESTOP II
(IN BRIEF) Carl Zeiss Meditec has named Kohnan Hospital as Japan’s first ZEISS Reference Center, creating a new hub for neurosurgical training and education. The centre will provide hands-on learning opportunities using advanced surgical microscope technology, addressing the growing need … Read the full press release
Posted in Business, Education, Financial, Germany, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Science, Technology
Tagged brain surgery, Carl Zeiss Meditec AG, clinical training, Healthcare Innovation, healthcare training center, Japan hospitals, Kohnan Hospital, medical education Japan, medical research, medical technology, neurosurgeons, neurosurgery training, New ZEISS Reference Center in Japan aims to strengthen surgical training and improve patient outcomes, Nobukazu Nakasato, patient outcomes, surgical best practices, surgical microscope, Tohoku University Hospital, Yoshimasa Tanaka, ZEISS KINEVO 900 S, ZEISS Reference Center
(IN BRIEF) Royal Philips, together with Erasmus MC and a broad consortium of industry, academic, and patient partners, has secured funding from the EU’s Innovative Health Initiative to coordinate the five-year SEISMIC research program aimed at transforming neurosurgery through the … Read the full press release
Posted in Business, Electronics & Machinery, European Union, Financial, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Marketing, Netherlands, Science, Technology
Tagged academia, and More Accessible Using Advanced Imaging, and Patients to Modernize Neurosurgical Care through Innovation, Bert van Meurs, Boston Scientific, Bracco, brain tumors, Cancer Patients Europe, Caresyntax, cryoablation, DEMCON Curix, Erasmus MC, EU-Backed SEISMIC Initiative Aims to Make Brain Surgery Safer, Faster, Fundacio Ictus, Hospital Clínic Barcelona, IDIBAPS, Innovative Health Initiative, intracerebral hemorrhage, medical imaging, minimally invasive neurosurgery, neurosurgical innovation, Oldelft Ultrasound, patient outcomes, Philips, Pieter Kruizinga, Public Private Partnership, Radboudumc, real-time navigation, Royal Philips, SEISMIC, SEISMIC Partnership Unites Industry, subdural hematoma, Surgical Science, ultrasound, UMC Utrecht, University of Ljubljana, us4us, Vall d’Hebron, VHIR, X-ray imaging, Yaskawa
(IN BRIEF) Fresenius Medical Care will showcase a variety of new research at the 62nd Congress of the European Renal Association (ERA) in Vienna, focusing on advancements in kidney care, artificial intelligence, fluid management, and hemodiafiltration. Key studies include the … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Science, Technology
Tagged AI, Andrea Nandorine Ban, artificial intelligence, CONVINCE trial, dialysis, ERA Congress, fluid management, Frank Maddux, Fresenius Medical Care, hemodiafiltration, hemodialysis, kidney disease, medical advancements, nephrology, patient outcomes, Renal Research Institute, RESEARCH
(IN BRIEF) The University of Exeter has developed a new algorithm for interpreting blood test results, helping GPs detect potential cancer warning signs earlier, particularly through variations in platelet count. The Royal Devon University Healthcare NHS Foundation Trust is the … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged algorithm, Australia, blood test, bowel cancer, CANADA, Cancer Detection, Cancers journal, David Walton, Devon, early diagnosis, early warning signs, England, Exeter HealthTech Research Centre, general practitioners, GP, High or Elevated Level of Platelets (HELP) Flag, lung cancer, medical research, National Institute for Health and Care Research, NHS, patient outcomes, personalized thresholds, platelet count, platelet variation, Professor Sarah Bailey, RDUH, Royal Devon University Healthcare NHS Foundation Trust, University of Exeter
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?